The strategic plan for combating antimicrobial resistance in Gulf Cooperation Council States

J Infect Public Health. 2016 Jul-Aug;9(4):375-85. doi: 10.1016/j.jiph.2016.03.003. Epub 2016 Apr 19.

Abstract

The Gulf Cooperation Council Center for Infection Control (GCC-IC) has placed the emergence of antimicrobial resistance (AMR) on the top of its agenda for the past four years. The board members have developed the initial draft for the GCC strategic plan for combating AMR in 2014. The strategic plan stems from the WHO mandate to combat AMR at all levels. The need for engaging a large number of stakeholders has prompted the GCC-IC to engage a wider core of professionals in finalizing the plan. A multi-disciplinary group of more than 40 experts were then identified. And a workshop was conducted in Riyadh January 2015 and included, for the first time, representation of relevant ministries and agencies as well as international experts in the field. Participants worked over a period of two and a half days in different groups. International experts shared the global experiences and challenges in addressing human, food, animal, and environmental aspects of controlling AMR. Participants were then divided into 4 groups each to address the human, animal, microbiological and diagnostic, or the environmental aspect of AMR. At the end of the workshop, the strategic plan was revised and endorsed by all participants. The GCC-IC board members then approved it as the strategic plan for AMR. The document produced here is the first GCC strategic plan addressing AMR, which shall be adopted by GCC countries to develop country-based plans and related key performance indicators (KPIs). It is now the role of each country to identify the body that will be accountable for implementing the plan at the country level.

Keywords: AMR; Antimicrobial resistance; Bahrain; GCC; Kuwait; Oman; Qatar; Saudi Arabia; Strategic plan; United Arab Emirates.

Publication types

  • Editorial

MeSH terms

  • Animals
  • Anti-Bacterial Agents / administration & dosage*
  • Drug Resistance, Bacterial*
  • Drug Utilization / standards*
  • Education
  • Health Policy*
  • Humans
  • Middle East

Substances

  • Anti-Bacterial Agents